5-Bromo-6-methoxybenzo[b]thiophene-2-carboxylic acid, 98%, 500mg

4,4,5,5-Tetramethyl-2-(4-(trifluoromethoxy)benzyl)-1,3,2-dioxaborolane, 95.0%, 25g

1-Boc-4-Chloroindole, 98%, 25g

5-Bromo-3-methoxypyridine 2-carbonitrile, 95.0%, 250mg

2-(4-Bromophenyl)-2,2-difluoroacetic acid, 95%, 1g

Fmoc-N-Me-Nle-OH, 95%, 5g

2-Methyl-1,4-phenylene Bis[4-[[[4-(acryloyloxy)butoxy]carbonyl]oxy]benzoate]>95.0%(HPLC)5g

Abiraterone acetate, 95.0%, 250mg

1-Boc-4-hydroxy-2-oxo-2,5-dihydro-pyrrol, 98.0%, 5g

(1R,2R)-METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOPROPANECARBOXYLATE, 95.0%, 5g

Ethyl 2-methyl-5-(4-nitrophenyl)furan-3-carboxylate, 95%, 250mg

2-(5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETAMIDE, 95.0%, 5g

(3-Acryloxypropyl)tris(trimethylsiloxy)silane inhibited with MEHQ tech-95, 95+%, 10g